Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03WAU
|
||||
Former ID |
DCL000049
|
||||
Drug Name |
Anamorelin
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Carbohydrate metabolism disorder [ICD10:E73-E74] | Phase 3 | [523546] | ||
Company |
Sapphire Therape.
|
||||
Structure |
Download2D MOL |
||||
Formula |
C31H42N6O3
|
||||
Canonical SMILES |
CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC(C3)(CC4=CC<br />=CC=C4)C(=O)N(C)N(C)C)N
|
||||
InChI |
1S/C31H42N6O3/c1-30(2,32)28(39)34-26(18-23-20-33-25-15-10-9-14-24(23)25)27(38)37-17-11-16-31(21-37,29(40)36(5)35(3)4)19-22-12-7-6-8-13-22/h6-10,12-15,20,26,33H,11,16-19,21,32H2,1-5H3,(H,34,39)/t26-,31-/m1/s1
|
||||
InChIKey |
VQPFSIRUEPQQPP-MXBOTTGLSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Growth hormone secretagogue receptor type 1 | Target Info | Stimulator | [537066] | |
NetPath Pathway | Leptin Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.